Celldex Therapeutics, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC CLDX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

117,589

Value ($000)

3,194

Weight

0.0%

2020 Q4 - 2025 Q4 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	3,194	0.0%	117,589	12/31/2025
2025 Q3	11/14/2025	2,729	0.0%	105,478	9/30/2025
2025 Q2	8/14/2025	4,352	0.0%	213,846	6/30/2025
2025 Q1	5/19/2025	2,383	0.0%	131,296	3/31/2025
2024 Q4	2/14/2025	2,939	0.0%	116,317	12/31/2024
2024 Q3	11/14/2024	3,487	0.0%	102,595	9/30/2024
2024 Q2	8/14/2024	3,565	0.0%	96,326	6/30/2024
2024 Q1	5/15/2024	1,625	0.0%	38,709	3/31/2024
2023 Q4	2/14/2024	1,383	0.0%	34,868	12/31/2023
2023 Q3	11/13/2023	960	0.0%	34,868	9/30/2023
2023 Q2	8/11/2023	1,142	0.0%	31,748	6/30/2023
2023 Q1	5/15/2023	1,142	0.0%	31,748	3/31/2023
2022 Q4	2/14/2023	1,348	0.0%	30,242	12/31/2022
2022 Q3	11/14/2022	850	0.0%	30,242	9/30/2022
2022 Q2	8/12/2022	794	0.0%	29,439	6/30/2022
2022 Q1	5/16/2022	1,127	0.0%	33,089	3/31/2022
2021 Q4	2/14/2022	1,279	0.0%	33,089	12/31/2021
2021 Q3	11/15/2021	1,955	0.0%	36,210	9/30/2021
2021 Q2	8/16/2021	1,137	0.0%	34,012	6/30/2021
2021 Q1	5/14/2021	729	0.0%	35,377	3/31/2021
2020 Q4	3/1/2021	595	0.0%	33,987	12/31/2020